IPROMOMED IPROMOMED

IPROMOMED

PRMD

Rank in Stocks #8335
Operating out of Russia, iPROMOMED functions as a pharmaceutical and... Operating out of Russia, iPROMOMED functions as a pharmaceutical and biotechnology enterprise dedicated to the research, production, and commercialization of both traditional prescription medications and cutting-edge therapeutic solutions.
Share Price
$5.11
Last synced: 2026-11-09
Market Cap
$1.09B
Change (1 day)
-0.29%
Change (1 year)
7.31%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for IPROMOMED (PRMD)
EPS as of June 2026 TTM: $0.53
According to IPROMOMED's latest financial reports, its current EPS (TTM) is $0.53. At the end of 2025 the company had an EPS of $0.45, an increase over its 2024 EPS of $0.13.
EPS history for IPROMOMED from 2019 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $0.53 17.60%
2025 $0.45 248.83%
2024 $0.13 -22.64%
2023 $0.17 -42.16%
2022 $0.29 -27.48%
2021 $0.39 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$6.50 1,128.53%
DE
$6.08 1,048.45%
DE
$1.55 193.01%
JP
$3.66 591.61%
CH
$0.45 -14.97%
IL

Questions about IPROMOMED's earnings per share (EPS)

What is IPROMOMED's earnings per share (EPS)?

IPROMOMED's earnings per share (EPS) over the last twelve months is $0.53, as of Jun 2026.

What was IPROMOMED's earnings per share (EPS) in 2025?

In 2025, IPROMOMED's earnings per share (EPS) was $0.45, 246.15% more than in 2024 ($0.13).

How has IPROMOMED's earnings per share (EPS) changed since 2020?

From 2020 to 2025, IPROMOMED's earnings per share (EPS) was highest in 2025 ($0.45) and lowest in 2020 (0.00).

How does IPROMOMED's earnings per share (EPS) compare with similar companies?

IPROMOMED's earnings per share (EPS) ($0.53) is higher than that of 1 of the 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.